173 related articles for article (PubMed ID: 34445551)
1. Expression of Alternative Splice Variants of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase-4 in Normoxic and Hypoxic Melanoma Cells.
Trojan SE; Dudzik P; Totoń-Żurańska J; Laidler P; Kocemba-Pilarczyk KA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445551
[TBL] [Abstract][Full Text] [Related]
2. Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.
Minchenko OH; Opentanova IL; Ogura T; Minchenko DO; Komisarenko SV; Caro J; Esumi H
Acta Biochim Pol; 2005; 52(4):881-8. PubMed ID: 16025159
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of
Trojan SE; Piwowar M; Ostrowska B; Laidler P; Kocemba-Pilarczyk KA
Anticancer Res; 2018 Dec; 38(12):6745-6752. PubMed ID: 30504385
[TBL] [Abstract][Full Text] [Related]
4. Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: expression and hypoxic regulation.
Minchenko OH; Ogura T; Opentanova IL; Minchenko DO; Esumi H
Mol Cell Biochem; 2005 Dec; 280(1-2):227-34. PubMed ID: 16311927
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
[TBL] [Abstract][Full Text] [Related]
6. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
Ros S; Flöter J; Kaymak I; Da Costa C; Houddane A; Dubuis S; Griffiths B; Mitter R; Walz S; Blake S; Behrens A; Brindle KM; Zamboni N; Rider MH; Schulze A
Oncogene; 2017 Jun; 36(23):3287-3299. PubMed ID: 28092678
[TBL] [Abstract][Full Text] [Related]
7. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
[TBL] [Abstract][Full Text] [Related]
8. Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism.
Li B; Takeda K; Ishikawa K; Yoshizawa M; Sato M; Shibahara S; Furuyama K
Tohoku J Exp Med; 2012 Sep; 228(1):27-41. PubMed ID: 22892400
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells.
Zhang H; Lu C; Fang M; Yan W; Chen M; Ji Y; He S; Liu T; Chen T; Xiao J
Biochem Biophys Res Commun; 2016 Jul; 476(3):146-52. PubMed ID: 27181362
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β1 upregulates 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-4 expression in A549 and MCF-10A cells.
Altunok TH; Muchut RJ; Iglesias AA; Yalcin A
Cell Biochem Funct; 2023 Dec; 41(8):1220-1229. PubMed ID: 37707291
[TBL] [Abstract][Full Text] [Related]
11. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
12. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
[TBL] [Abstract][Full Text] [Related]
13. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
15. Expression of mouse 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 mRNA alternative splice variants in hypoxia.
Mykhalchenko VG; Minchenko DO; Tsuchihara K; Moenner M; Komisarenko SV; Bikfalvi A; Esumi H; Minchenko OH
Ukr Biokhim Zh (1999); 2008; 80(1):19-25. PubMed ID: 18710022
[TBL] [Abstract][Full Text] [Related]
16. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.
Minchenko OH; Tsuchihara K; Minchenko DO; Bikfalvi A; Esumi H
World J Gastroenterol; 2014 Oct; 20(38):13705-17. PubMed ID: 25320508
[TBL] [Abstract][Full Text] [Related]
18. PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer.
Cai YC; Yang H; Shan HB; Su HF; Jiang WQ; Shi YX
Dis Markers; 2021; 2021():8824589. PubMed ID: 34211613
[TBL] [Abstract][Full Text] [Related]
19. Pfkfb (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) isoforms display a tissue-specific and dynamic expression during Xenopus laevis development.
Pegoraro C; Maczkowiak F; Monsoro-Burq AH
Gene Expr Patterns; 2013 Oct; 13(7):203-11. PubMed ID: 23623824
[TBL] [Abstract][Full Text] [Related]
20. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
